|Test||HIV 1/2 ANTIBODIES AND HIV ANTIGEN (4TH GENERATION)|
|Methodology||Chemiluminescent Microparticle Immunoassay (CMIA)|
|Description||Useful for the simultaneous qualitative detection of antibodes to Human Immunodeficiency Virus (HIV), Type 1 (HIV-1 group M and group O) and/or Type 2, and of HIV p24 antigen.
NOTE: This test should not be ordered on children less than 2 years of age. The recommended test for this population is "HIV-1 RNA VIRAL LOAD (HIVVL)
NOTE: Reactive (positive) specimens reflex to HIVSP, HIV 1 + HIV 2 Differentiation Test at an additional charge.
NOTE: This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policy " Human Immunodeficiency Virus (HIV) Testing (Diagnosis)". Please verify that the diagnosis code (ICD-9) you have chosen demonstrates medical necessity for the test as documented in the physician's patient record. The CMS web site or the NorDx Medical Necessity Reference Guide are available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD-9 code chosen or if the frequency of a frequency-limited test is unknown.
|Specimen||Draw blood in either a plain, red-top tube or a serum gel tube. (GROSSLY HEMOLYZED, OR LIPEMIC SPECIMENS ARE NOT ACCEPTABLE.) Spin down and send 2.0 mL (1.5 mL minimum) of serum refrigerated.
NOTE: THE FOLLOWING SPECIMENS WILL NOT BE TESTED:
|Reference Values||Negative (reported as negative or positive)|
|Analytic Time||1 Day (for negatives)|
|Day(s) Test Set Up||Monday through Friday|
86701, 86702 HIV 1 Ab Differentiation, HIV 2 Ab Differentiation (if appropriate)
87389 HIV1/2 Antibodies